Regal Investment Advisors LLC Biogen Inc. Transaction History

Regal Investment Advisors LLC

$1.49 Billion
Q2 2024

A detailed history of Regal Investment Advisors LLC transactions in Biogen Inc. stock. As of the latest transaction made, Regal Investment Advisors LLC holds 1,633 shares of BIIB stock, worth $283,799. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,633

Previous 1,653 1.21%

Holding current value

$283,799

Previous $356,000 6.18%

% of portfolio

0.03%

Previous 0.02%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$190.52 - $236.72 $3,810 - $4,734	-20 Reduced 1.21%	1,633 $378,000
Q3 2023 Nov 13, 2023	BUY	$253.3 - $285.89 $1,013 - $1,143	4 Added 0.24%	1,653 $424,000
Q1 2023 May 11, 2023	BUY	$256.56 - $292.34 $19,755 - $22,510	77 Added 4.9%	1,649 $458,000
Q4 2022 Mar 01, 2023	SELL	$252.44 - $306.72 $8,835 - $10,735	-35 Reduced 2.18%	1,572 $435,000
Q3 2022 Nov 15, 2022	SELL	$194.69 - $268.46 $3,504 - $4,832	-18 Reduced 1.11%	1,607 $429,000
Q2 2022 Aug 09, 2022	SELL	$187.54 - $223.02 $6,563 - $7,805	-35 Reduced 2.11%	1,625 $331,000
Q1 2022 May 09, 2022	SELL	$193.77 - $244.14 $1.07 Million - $1.35 Million	-5,526 Reduced 76.9%	1,660 $349,000
Q4 2021 Feb 10, 2022	BUY	$223.92 - $287.77 $495,758 - $637,122	2,214 Added 44.53%	7,186 $1.72 Million
Q3 2021 Nov 05, 2021	BUY	$282.99 - $369.05 $787,844 - $1.03 Million	2,784 Added 127.24%	4,972 $1.41 Million
Q2 2021 Aug 09, 2021	BUY	$259.0 - $414.71 $566,692 - $907,385	2,188 New	2,188 $758,000
Q1 2021 May 12, 2021	SELL	$242.95 - $284.63 $880,450 - $1.03 Million	-3,624 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$236.26 - $355.63 $856,206 - $1.29 Million	3,624 New	3,624 $887,000
Q1 2020 May 12, 2020	SELL	$268.85 - $341.04 $1.6 Million - $2.03 Million	-5,953 Closed	0 $0
Q4 2019 Jan 29, 2020	SELL	$220.06 - $304.07 $21,125 - $29,190	-96 Reduced 1.59%	5,953 $1.77 Million
Q3 2019 Nov 15, 2019	SELL	$217.44 - $243.88 $9,349 - $10,486	-43 Reduced 0.71%	6,049 $1.41 Million
Q2 2019 Jul 26, 2019	BUY	$219.29 - $241.72 $48,024 - $52,936	219 Added 3.73%	6,092 $1.43 Million
Q1 2019 May 09, 2019	BUY	$216.71 - $338.96 $13,002 - $20,337	60 Added 1.03%	5,873 $1.39 Million
Q4 2018 Feb 04, 2019	BUY	$278.5 - $352.75 $1.62 Million - $2.05 Million	5,813 New	5,813 $1.75 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Regal Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regal Investment Advisors LLC with notifications on news.

Account

Regal Investment Advisors LLC Biogen Inc. Transaction History